Ocular Therapeutix Inc
OCUL
$12.31-0.31 (-2.46%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 12.91 | 52Week Low | 5.79 |
| Beta | 1.46 | Current Ratio Annual | 10.66 |
| Current Ratio Quarterly | 10.09 | Gross Margin TTM | 89.42 |
| Market Cap | 2.20B | Net Profit Margin TTM | -382.51 |
| Operating Margin TTM | -402.60 | Price To Book | 7.18 |
| Price To Sales TTM | 38.75 | Quick Ratio Annual | 10.26 |
| Quick Ratio Quarterly | 9.82 | Return On Assets TTM | -48.02 |
| Return On Equity TTM | -69.96 | Return On Investment TTM | -57.24 |
| Revenue Growth3Y | 13.55 | Revenue Growth5Y | 72.02 |
| Revenue Growth Quarterly Yoy | -17.83 | Revenue Growth TTMYoy | -7.16 |
| Revenue Per Share TTM | 0.33 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 184 | 3 | 0 | 6 | 2 | 1 | 134.29M | $1.13B |
| Mar 31, 2025 | 197(+7%) | 32(+967%) | 18(+%) | 62(+933%) | 56(+2700%) | 43(+4200%) | 137.79M(+3%) | $1B(-12%) |
| Jun 30, 2025 | 185(-6%) | 18(-44%) | 30(+67%) | 72(+16%) | 48(-14%) | 40(-7%) | 155.28M(+13%) | $1.43B(+43%) |